focus -WSS

focus

author：comprehensive 2025-10-02 01:08:38 - browse：95

The FDA building -- First Opinion coverage from STAT — Adobe

The clearance of a first-of-its-kind cancer treatment made by Amgen is on shakier ground following a Food and Drug Administration advisory committee meeting Thursday.

Regulatory advisers voted 10-2 that the data on the company’s drug Lumakras, a treatment for lung cancer, could not be properly assessed. Lumakras targets a specific mutation to a protein called KRAS, which is one of the most common genetic mutations in cancer.

The vote comes as Amgen is hoping to convert a conditional approval for the drug to a full approval based on a 345-person study called CodeBreaK 200, in which Lumakras met the primary endpoint, delaying tumor growth approximately five weeks longer than the standard of care medication, docetaxel. The drug didn’t extend patients’ overall survival.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Twill hunts for pharma partner to market its depression app

WSS

Study: Hearing aids may slow cognitive decline in those at risk

Robert Kennedy Jr.'s presidential campaign attracts GOP

House passes resolution saying Israel isn't a 'racist or apartheid state'

House passes resolution saying Israel isn't a 'racist or apartheid state'

Slain Parkland victim's father speaks out following reenactment

A strong 6.5

explore

focus

focus

Heart attack and stroke risk calculators need revising

Pharma needs to include young adults in clinical research

ChatGPT in medicine: STAT answers readers' burning questions

A look at other Americans who have crossed into North Korea over the years

In age of alternative facts, a scholarly course on calling out crap

Twill hunts for pharma partner to market its depression app

Jerome Adams on the need for new antivirals for Covid

Johnson & Johnson sues to stop Medicare negotiation

Apple is now the first public company to be valued at $3 trillion

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

hotspot

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Prosecutors seek bail revocation for FTX founder Sam Bankman

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Study: Hearing aids may slow cognitive decline in those at risk

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Wikipedia

focus

hotspot

hotspot